Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 14/20 | 0.36 |
| ▸ | P2RX2 | Q9UBL9 | 9/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4355291 | 0.81 | SOS1 (0.34) | P2RX3TRPV1 | |
| SCHEMBL2847817 | 0.79 | APP (0.41) | TRPV1 | |
| SCHEMBL4759238 | 0.77 | P2RX3 (0.58) | P2RX3P2RX2 | |
| SCHEMBL2862214 | 0.77 | P2RX3 (0.58) | P2RX3P2RX2 | |
| SCHEMBL2866604 | 0.76 | P2RX3 (0.55) | P2RX3P2RX2MCHR1TRPV1 | |
| SCHEMBL2862215 | 0.74 | P2RX3 (0.45) | P2RX3P2RX2GRIN2BMCHR1 | |
| SCHEMBL2846226 | 0.72 | TRPV1 (0.57) | TRPV1 | |
| SCHEMBL2847843 | 0.72 | TRPV1 (0.40) | TRPV1 | |
| SCHEMBL8251107 | 0.70 | TRPV1 (0.52) | TRPV1 | |
| SCHEMBL4868312 | 0.70 | APP (0.41) | TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2139334-A1 | 2-CYANOPHENYL FUSED HETEROCYCLIC COMPOUNDS, AND COMPOSITIONS AND USES THEREOF | Renovis, Inc. (US) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008130481-A1 | 2-CYANOPHENYL FUSED HETEROCYCLIC COMPOUNDS, AND COMPOSITIONS AND USES THEREOF | RENOVIS, INC. (US) | 2008-10-30 | — | — | WO | disclosed |